However, in myeloid cancers such as MDS, CML, and CLL, STING expression was negatively correlated with M2 macrophages (Figure 4B), suggesting a potential context-dependent role of STING in shaping the immune microenvironment. Here, STING1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.